Get the Stockscreener App
4.07
2.63%
-0.11
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Oramed Pharmaceuticals Inc Stock (ORMP) Forecast
The Oramed Pharmaceuticals Inc (ORMP) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.9717, representing a +71.30% increase from the current price of $4.07. The highest analyst price target is $13.07, and the lowest is $0.8702.
Note: Our forecast model does not currently account for dividend and stock split events. This means that our forecast may not be accurate for stocks that have recently experienced either of these events.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ORMP Price Target
Average 6.9717
(+71.30% Upside)
Is Oramed Pharmaceuticals Inc (ORMP) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.21 | Neutral |
| STOCH(9,6) | 14.14 | Buy |
| STOCHRSI(14) | 4.7297 | Buy |
| MACD(12,26) | -0.1522 | Sell |
| ADX(14) | 28.03 | Sell |
| William %R | -90.06 | Buy |
| CCI(14) | -88.33 | Neutral |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.266
Sell
|
4.2617
Sell
|
| MA20 |
4.4715
Sell
|
4.4002
Sell
|
| MA50 |
4.6386
Sell
|
4.4923
Sell
|
| MA100 |
4.3702
Sell
|
4.358
Sell
|
| MA200 |
3.9875
Buy
|
3.9434
Buy
|
Buy: 2
Sell: 8
Neutral: 0
Summary: Sell
According to our latest analysis, ORMP could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 10 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on ORMP, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.21 indicates that ORMP is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.14 indicates that ORMP is oversold. This indicates that ORMP price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.7297 indicates that ORMP is oversold. This suggests that ORMP price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.03 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -88.33 indicates that ORMP is still oversold but not to an extreme extent.
Long-term ORMP price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Oramed Pharmaceuticals Inc financial reports and earnings history, Oramed Pharmaceuticals Inc (ORMP) stock could reach $7.3524 by 2030, $36.52 by 2040 and $79.33 by 2050. See the projected annual prices until 2050 of the Oramed Pharmaceuticals Inc stock below:
- Oramed Pharmaceuticals Inc (ORMP) is expected to reach an average price of $20.14 in 2035, with a high prediction of $21.06 and a low estimate of $20.41. This indicates an $394.90% rise from the last recorded price of $4.07.
- Oramed Pharmaceuticals Inc (ORMP) stock is projected to chart a bullish course in 2040, with an average price target of $36.59, representing an $798.91% surge from its current level. The forecast ranges from a conservative $36.64 to a sky-high $36.52.
- Our analysts predict Oramed Pharmaceuticals Inc (ORMP) to jump 1,172% by 2045, soaring from $52.11 to an average price of $51.77, potentially reaching $52.37. While $52.11 is the low estimate, the potential upside is significant.
- Oramed Pharmaceuticals Inc (ORMP) stock is expected to climb by 2050, reaching an average of $78.90, a $1,839% jump from its current level. However, a wide range of estimates exists, with high and low targets of $79.33 and $79.53, respectively, highlighting the market's uncertainty.
Oramed Pharmaceuticals Inc Stock (ORMP) Year by Year Forecast
Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2026
The predicted value for Oramed Pharmaceuticals Inc (ORMP) in 2026 is set at an average of $6.9717. Estimates vary from a peak of $13.07 to a trough of $0.8702, indicating an +71.30% surge from the present price of $4.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.9598 | $0.8702 | $13.07 | -76.42% |
| December, 2026 | $2.5337 | $3.0186 | $2.2537 | -37.75% |
Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Oramed Pharmaceuticals Inc (ORMP) is $8.7942, with a high forecast of $12.31 and a low forecast of $5.282. This indicates an +116.07% increase from the last price of $4.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.9321 | $5.282 | $6.7471 | +119.46% |
| February, 2027 | $6.3106 | $6.5506 | $8.7539 | +55.05% |
| March, 2027 | $8.2724 | $7.159 | $7.5824 | +103.25% |
| April, 2027 | $8.5259 | $8.1542 | $8.2709 | +109.48% |
| May, 2027 | $11.85 | $9.2643 | $11.00 | +191.10% |
| June, 2027 | $12.08 | $12.10 | $11.87 | +196.84% |
| July, 2027 | $11.60 | $12.30 | $12.31 | +185.13% |
| August, 2027 | $7.5065 | $8.2515 | $11.65 | +84.44% |
| September, 2027 | $6.90 | $7.39 | $7.3349 | +69.53% |
| October, 2027 | $7.3135 | $7.6684 | $7.3201 | +79.69% |
| November, 2027 | $9.3353 | $8.2418 | $9.1453 | +129.37% |
| December, 2027 | $8.7688 | $8.50 | $8.4637 | +115.45% |
Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2028
In 2028, Oramed Pharmaceuticals Inc (ORMP) is projected to reach an average price of $8.2192, with a high projection of $12.61 and a low estimate of $3.8324. This indicates an +101.95% rise from the last price of $4.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.4606 | $7.2222 | $7.7571 | +58.74% |
| February, 2028 | $2.8741 | $4.5091 | $6.3423 | -29.38% |
| March, 2028 | $12.76 | $3.8324 | $12.60 | +213.45% |
| April, 2028 | $12.31 | $12.38 | $12.61 | +202.48% |
| May, 2028 | $12.00 | $12.21 | $12.25 | +194.91% |
| June, 2028 | $11.79 | $11.92 | $11.94 | +189.59% |
| July, 2028 | $9.3082 | $10.78 | $11.63 | +128.70% |
| August, 2028 | $9.6988 | $9.6783 | $9.435 | +138.30% |
| September, 2028 | $9.8851 | $9.73 | $9.7551 | +142.88% |
| October, 2028 | $9.6769 | $9.8419 | $9.9102 | +137.76% |
| November, 2028 | $9.6104 | $9.7504 | $9.6937 | +136.13% |
| December, 2028 | $10.08 | $9.5388 | $9.6539 | +147.76% |
Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2029
The 2029 price forecast for Oramed Pharmaceuticals Inc Stock (ORMP) is $9.0556 on average, with a high prediction of $10.48 and a low estimate of $7.6339. This represents an +122.50% increase from the previous price of $4.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $10.58 | $10.13 | $10.42 | +159.85% |
| February, 2029 | $10.17 | $10.35 | $10.48 | +149.86% |
| March, 2029 | $9.7726 | $9.9126 | $9.8775 | +140.11% |
| April, 2029 | $9.4145 | $9.5261 | $9.4977 | +131.31% |
| May, 2029 | $8.7979 | $8.8979 | $9.3528 | +116.17% |
| June, 2029 | $8.0514 | $8.1314 | $8.5463 | +97.82% |
| July, 2029 | $8.1632 | $7.9998 | $8.1165 | +100.57% |
| August, 2029 | $8.4167 | $8.48 | $8.3967 | +106.80% |
| September, 2029 | $8.3702 | $8.4013 | $8.3451 | +105.66% |
| October, 2029 | $8.112 | $8.232 | $8.2453 | +99.31% |
| November, 2029 | $7.6555 | $7.7055 | $7.6589 | +88.10% |
| December, 2029 | $7.6073 | $7.6339 | $7.599 | +86.91% |
Oramed Pharmaceuticals Inc Stock (ORMP) Price Forecast for 2030
Oramed Pharmaceuticals Inc Stock (ORMP) is expected to reach an average price of $6.2574 in 2030, with a high forecast of $7.3524 and a low forecast of $5.1624. This signifies an +53.75% surge from the last price of $4.07.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $7.2508 | $7.4408 | $7.3524 | +78.15% |
| February, 2030 | $7.1843 | $7.1459 | $7.1492 | +76.52% |
| March, 2030 | $6.9477 | $7.0777 | $7.0526 | +70.71% |
| April, 2030 | $6.6996 | $6.7696 | $6.8861 | +64.61% |
| May, 2030 | $6.493 | $6.523 | $6.453 | +59.53% |
| June, 2030 | $6.3765 | $6.3381 | $6.3664 | +56.67% |
| July, 2030 | $6.2483 | $6.2883 | $6.2732 | +53.52% |
| August, 2030 | $5.8618 | $5.8788 | $6.1267 | +44.02% |
| September, 2030 | $5.7837 | $5.7937 | $5.8597 | +42.10% |
| October, 2030 | $5.4771 | $5.5088 | $5.542 | +34.57% |
| November, 2030 | $5.3006 | $5.5206 | $5.4339 | +30.24% |
| December, 2030 | $5.0824 | $5.1624 | $5.2173 | +24.88% |
4.22%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):